MaxCyte
Quarterly Financials
| Values in thousands | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 |
|---|---|---|---|---|
Revenue | $7,300 | $6,829 | $8,507 | $10,390 |
Gross Profit | 4,610 | 6,313 | 6,988 | 8,893 |
EBITDA | -6,600 | -11,568 | -12,930 | -11,018 |
EBIT | -7,672 | -12,416 | -14,227 | -12,295 |
Net Income | -9,596 | -12,416 | -12,357 | -10,261 |
Net Change In Cash | 7,300 | 6,829 | 8,507 | 10,390 |
Free Cash Flow | -2,920 | -7,758 | -10,436 | -15,064 |
Cash | 20,065 | 12,973 | 15,225 | 23,385 |
Basic Shares | 106,427 | 106,324 | 106,403 | 105,950 |
Annual Financials
| Values in thousands | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
Revenue | $33,026 | $38,627 | $41,288 | $44,261 |
Gross Profit | 26,804 | 31,527 | 36,546 | 39,163 |
EBITDA | -40,143 | -46,407 | -44,128 | -24,663 |
EBIT | -45,285 | -51,197 | -48,299 | -27,361 |
Net Income | -44,630 | -41,055 | -37,923 | -23,571 |
Net Change In Cash | 33,026 | 38,627 | 41,288 | 44,261 |
Cost of Revenue | -36,717 | |||
Free Cash Flow | -36,178 | -29,261 | -25,386 | -33,260 |
Cash | 20,065 | 27,884 | 46,506 | 11,065 |
Basic Shares | 106,427 | 104,849 | 103,268 | 101,702 |
Earnings Calls
| Quarter | EPS |
|---|---|
2026-03-31 | $0 |
2025-12-31 | -$0.05 |
2025-09-30 | -$0.12 |
2025-06-30 | -$0.12 |
